273 related articles for article (PubMed ID: 31856437)
1. [Anti-myelin-associated glycoprotein antibody positive IgM monoclonal gammopathy related peripheral neuropathy: 11 cases and literature review].
Gao XM; Jia MN; Qian M; Ren HT; Zhang L; Shen KN; Cao XX; Li J
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):901-905. PubMed ID: 31856437
[No Abstract] [Full Text] [Related]
2. Serum neurofilament light chain, contactin-1 and complement activation in anti-MAG IgM paraprotein-related peripheral neuropathy.
Amaador K; Wieske L; Koel-Simmelink MJA; Kamp A; Jongerius I; de Heer K; Teunissen CE; Minnema MC; Notermans NC; Eftimov F; Kersten MJ; Vos JMI
J Neurol; 2022 Jul; 269(7):3700-3705. PubMed ID: 35157138
[TBL] [Abstract][Full Text] [Related]
3. Clinical, electrophysiological and immunological study of peripheral nerves in Egyptian patients with monoclonal gammopathies.
El-Difrawy MM; Zaki NE; Marouf HM; Ayad MW; Farag AM
Int J Hematol; 2012 Jan; 95(1):71-6. PubMed ID: 22193843
[TBL] [Abstract][Full Text] [Related]
4. Peripheral neuropathy in IgM monoclonal gammopathy and Wäldenstrom's macroglobulinemia: a frequent complication in elderly males with low MAG-reactive serum monoclonal component.
Baldini L; Nobile-Orazio E; Guffanti A; Barbieri S; Carpo M; Cro L; Cesana B; Damilano I; Maiolo AT
Am J Hematol; 1994 Jan; 45(1):25-31. PubMed ID: 7504399
[TBL] [Abstract][Full Text] [Related]
5. Myelin modifications in 8 cases of peripheral neuropathy with Waldenström's macroglobulinemia and anti-MAG activity.
Vital C; Vital A; Deminiere C; Julien J; Lagueny A; Steck AJ
Ultrastruct Pathol; 1997; 21(6):509-16. PubMed ID: 9355233
[TBL] [Abstract][Full Text] [Related]
6. IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy.
Campagnolo M; Zambello R; Nobile-Orazio E; Benedetti L; Marfia GA; Riva N; Castellani F; Bianco M; Salvalaggio A; Garnero M; Ruiz M; Mataluni G; Fazio R; Ermani M; Briani C
J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1094-1097. PubMed ID: 28501820
[No Abstract] [Full Text] [Related]
7. Mutational Profile in 75 Patients With Anti-Myelin-Associated Glycoprotein Neuropathy: Clinical and Hematologic Therapy Response and Hints on New Therapeutic Targets.
Castellani F; Visentin A; Schirinzi E; Salvalaggio A; Cacciavillani M; Candiotto C; Baratè C; Cellini A; Bertorelle R; Siciliano G; Trentin L; Briani C
Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37137530
[TBL] [Abstract][Full Text] [Related]
8. Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody.
Kawagashira Y; Koike H; Ohyama K; Hashimoto R; Iijima M; Adachi H; Katsuno M; Chapman M; Lunn M; Sobue G
J Neurol Sci; 2015 Jan; 348(1-2):67-73. PubMed ID: 25467141
[TBL] [Abstract][Full Text] [Related]
9. [Peripheral neuropathy with monoclonal gammopathy].
Meier T; Meyer M
Schweiz Med Wochenschr; 1990 Mar; 120(12):417-25. PubMed ID: 2157280
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Expression of Nodal and Paranodal Molecules in Neuropathy Associated With IgM Monoclonal Gammopathy With Anti-Myelin-Associated Glycoprotein Antibodies.
Kawagashira Y; Koike H; Takahashi M; Ohyama K; Iijima M; Katsuno M; Niwa JI; Doyu M; Sobue G
J Neuropathol Exp Neurol; 2020 Dec; 79(12):1303-1312. PubMed ID: 32856086
[TBL] [Abstract][Full Text] [Related]
11. Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy.
Al-Zuhairy A; Schrøder HD; Plesner T; Abildgaard N; Sindrup SH
J Neurol Sci; 2015 Feb; 349(1-2):60-4. PubMed ID: 25582978
[TBL] [Abstract][Full Text] [Related]
12. Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy.
Pascual-Goñi E; Martín-Aguilar L; Lleixà C; Martínez-Martínez L; Simón-Talero MJ; Díaz-Manera J; Cortés-Vicente E; Rojas-García R; Moga E; Juárez C; Illa I; Querol L
Sci Rep; 2019 Apr; 9(1):6155. PubMed ID: 30992531
[TBL] [Abstract][Full Text] [Related]
13. Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).
Kvarnstrom M; Sidorova E; Nilsson J; Ekerfelt C; Vrethem M; Soderberg O; Johansson M; Rosen A; Ernerudh J
Clin Exp Immunol; 2002 Feb; 127(2):255-62. PubMed ID: 11876747
[TBL] [Abstract][Full Text] [Related]
14. [A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity].
Nakamura H; Endo M; Sugawara E; Kuwahara M; Kusunoki S; Tanaka F; Takahashi T
Rinsho Shinkeigaku; 2013; 53(10):799-802. PubMed ID: 24225562
[TBL] [Abstract][Full Text] [Related]
15. Peripheral neuropathy as clinical onset of monoclonal IgM/k-related amyloidosis.
Briani C; Ferrari S; Berno T; Visentin A; Cacciavillani M; Cavallaro T; Fedrigo M; Rizzo S; Salvalaggio A; Trentin L; Piazza F
J Peripher Nerv Syst; 2023 Jun; 28(2):262-265. PubMed ID: 36859783
[TBL] [Abstract][Full Text] [Related]
16. [Polyneuropathy involving cranial nerves associated with monoclonal IgM antibodies with anti-MAG/SGPG/SGPLG/sulfatides activity].
Drouet A; Caudie C; Vallat JM; Ruel JH; Felten D; Guilloton L; Giraud P
Rev Neurol (Paris); 2006 Jun; 162(6-7):760-6. PubMed ID: 16840988
[TBL] [Abstract][Full Text] [Related]
17. Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy.
Gabriel JM; Erne B; Bernasconi L; Tosi C; Probst A; Landmann L; Steck AJ
Acta Neuropathol; 1998 May; 95(5):540-6. PubMed ID: 9600601
[TBL] [Abstract][Full Text] [Related]
18. Polyneuropathy associated with IgM monoclonal gammopathy: a review. Clinical, electrophysiological and pathological features.
Leger JM; Vaunaize J
Nouv Rev Fr Hematol (1978); 1990; 32(5):303-6. PubMed ID: 1965990
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of autoantibodies to MAG by ELISA Bühlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG/SGLPG].
Caudie C; Kaygisiz F; Jaquet P; Petiot P; Gonnaud PM; Antoine JC; Vial C
Ann Biol Clin (Paris); 2006; 64(4):353-9. PubMed ID: 16829480
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the spectrum of IgM-related neuropathies in a large cohort of IgM monoclonal gammopathy.
Bardel B; Molinier-Frenkel V; Le Bras F; Ayache SS; Nordine T; Lefaucheur JP; Planté-Bordeneuve V
J Neurol; 2022 Sep; 269(9):4955-4960. PubMed ID: 35505107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
